The Angelini Pharma Inc. Team
Todd W. Maddock, CEO
Mr. Maddock has over 25 years of leadership experience, with the majority of his career at General Electric. His past leadership roles include Vice President, General Manager, VP of Sales, and VP of Global Marketing. Todd has broad healthcare experience including medical device, consumables, capital equipment, service, and financing. He also brings extensive experience in infection prevention from his days working at STERIS, and strong wound care experience from his time working at Procter & Gamble, representing the 3M line of wound care. Todd graduated from the University of Connecticut, School of Business, and participated in varsity athletics.
Ludovico (Vico) Giavotto, President of Angelini Pharma
Mr. Giavotto has been an integral part of the Amuchina family since 1979 in Italy and later in the USA. His past positions include COO and CEO of Amuchina S.p.A. in Europe.
Douglas C. Clark, Director of Operations
In this role, Mr. Clark is responsible for the day to day operations of the company including Production, Logistics, Customer Service, HR and IT. Doug joined the Angelini team in 2015 after spending nearly 25 years with Verizon and predecessor companies where he held many leadership positions in Operations/Merger Integration, HR, and Finance. Mr. Clark holds a bachelor’s degree in Accounting from the University of Connecticut and is a Certified Public Accountant.
Philippe Befferal, BA, Chief Financial Officer
Mr. Befferal brings over 18 years of experience in the pharmaceutical industry both at Corporate and Subsidiary level in international environments. Mr. Befferal joined Angelini in 2011 for the launch of OleptroTM in the US market. Prior to joining Angelini Mr. Befferal was employed by Patheon (a leading provider of contract drug development and manufacturing services) at their European headquarters in Switzerland as Director of Quotations and Reporting Europe. From 1995 to 2005 Mr. Befferal held several positions at Lundbeck (a leading company in the CNS market) first as Finance Director of the French subsidiary in Paris, Business Support Manager Europe in Copenhagen, Finance Director South Europe in Rome and Senior Director Admin Operations in New York. Mr. Befferal is a French citizen and speaks French, Italian and English and has extensive knowledge in commercial operations projects such as CRM implementation, Balanced Scorecard model roll-out, Sales Force expansion and business intelligence tools implementation.
Hippolitus Odukwu, MS, Director of Quality and Regulatory Affairs
In this role, Mr. Odukwu is responsible for defining and orchestrating the regulatory strategy at Angelini Pharma Inc. He possesses an extensive background in drug and device development, having spent over 20 years in the industry. Mr. Odukwu holds a bachelor’s degree in microbiology from the University of Nigeria and a master’s in Chemistry from George Mason University.
Steven Adler, BS, Director Business Development, Manager Wound Care Division, Manager Device Division
Mr. Adler has accumulated more than 30 years of experience in marketing, sales and sales management. Steve joined the company in 2006, previously working for Nephros Inc. as the Director of Marketing with International responsibilities. In 2012 he was appointed manager/leader of the Device Division and the newly formed Wound Care Division. Mr. Adler has a BS in Biology from CCNY. Reporting to both the COO and CEO, Mr. Adler has grown with the company through both mergers and acquisitions.
Richard Moncure, BS: National Sales Manager, Renal
Mr. Moncure has over 25 years of Medical Sales experience. He has worked within the dialysis industry 20 of these years. He received a BS in Communications, with a minor in Business Administration from Western Carolina University. He always strives to be an exceptional partner to his customers, providing industry expertise and clinical support. He has grown with the company through both acquisitions and mergers.